Development and validation of an individual-based state-transition model for the prediction of frailty and frailty-related events.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
08
2022
accepted:
09
08
2023
medline:
28
8
2023
pubmed:
24
8
2023
entrez:
24
8
2023
Statut:
epublish
Résumé
Frailty is a biological syndrome that is associated with increased risks of morbidity and mortality. To assess the value of interventions to prevent or manage frailty, all important impacts on costs and outcomes should be estimated. The aim of this study is to describe the development and validation of an individual-based state transition model that predicts the incidence and progression of frailty and frailty-related events over the remaining lifetime of older Australians. An individual-based state transition simulation model comprising integrated sub models that represent the occurrence of seven events (mortality, hip fracture, falls, admission to hospital, delirium, physical disability, and transitioning to residential care) was developed. The initial parameterisation used data from the Survey of Health, Ageing, and Retirement in Europe (SHARE). The model was then calibrated for an Australian population using data from the Household, Income and Labour Dynamics in Australia (HILDA) Survey. The simulation model established internal validity with respect to predicting outcomes at 24 months for the SHARE population. Calibration was required to predict longer terms outcomes at 48 months in the SHARE and HILDA data. Using probabilistic calibration methods, over 1,000 sampled sets of input parameter met the convergence criteria across six external calibration targets. The developed model provides a tool for predicting frailty and frailty-related events in a representative community dwelling Australian population aged over 65 years and provides the basis for economic evaluation of frailty-focussed interventions. Calibration to outcomes observed over an extended time horizon would improve model validity.
Identifiants
pubmed: 37616298
doi: 10.1371/journal.pone.0290567
pii: PONE-D-22-22275
pmc: PMC10449188
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0290567Informations de copyright
Copyright: © 2023 Pincombe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ageing Res Rev. 2019 Mar;50:81-88
pubmed: 30659942
PLoS One. 2019 Sep 11;14(9):e0222049
pubmed: 31509563
Australas J Ageing. 2018 Jun;37(2):155-158
pubmed: 29314622
J Am Med Dir Assoc. 2015 Jan;16(1):41-8
pubmed: 25239014
Age Ageing. 2014 Jan;43(1):10-2
pubmed: 24132852
J Am Med Dir Assoc. 2013 Jun;14(6):392-7
pubmed: 23764209
J Am Geriatr Soc. 2009 Mar;57(3):492-8
pubmed: 19245414
Int J Environ Res Public Health. 2019 Jun 13;16(12):
pubmed: 31200434
Int J Epidemiol. 2013 Aug;42(4):992-1001
pubmed: 23778574
Exp Gerontol. 2019 Aug;123:57-65
pubmed: 31129145
Eur J Public Health. 2012 Oct;22(5):671-7
pubmed: 21908861
J Geriatr Phys Ther. 2018 Jan/Mar;41(1):42-48
pubmed: 27341327
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
J Comp Eff Res. 2018 Aug;7(8):817-825
pubmed: 29808714
Clin Geriatr Med. 2021 Nov;37(4):625-638
pubmed: 34600727
J Gerontol A Biol Sci Med Sci. 2018 Jul 9;73(8):1090-1096
pubmed: 29985993
Int J Cardiol. 2021 Jun 15;333:133-140
pubmed: 33657397
BMJ. 2017 Sep 20;358:j4208
pubmed: 28931509
BMC Med. 2013 Mar 11;11:65
pubmed: 23497404
Med Decis Making. 2012 Sep-Oct;32(5):690-700
pubmed: 22990084
BMC Geriatr. 2016 Jul 07;16:133
pubmed: 27388294
BMC Geriatr. 2016 Nov 17;16(1):187
pubmed: 27855641
Ageing Res Rev. 2015 May;21:78-94
pubmed: 25846451
Int J Public Health. 2016 Apr;61(3):289-98
pubmed: 26747470
Age Ageing. 2017 May 1;46(3):383-392
pubmed: 28064173
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Pharmacoeconomics. 2014 Jun;32(6):547-58
pubmed: 24627341
Arch Intern Med. 2006 Feb 27;166(4):418-23
pubmed: 16505261
Appl Health Econ Health Policy. 2017 Oct;15(5):635-645
pubmed: 28349499
Eur J Health Econ. 2017 Mar;18(2):243-253
pubmed: 26914932
Lancet Public Health. 2018 Jul;3(7):e323-e332
pubmed: 29908859
J Am Geriatr Soc. 2011 Mar;59(3):524-9
pubmed: 21391943
Eur J Health Econ. 2012 Aug;13(4):501-10
pubmed: 21633818
Sci Rep. 2022 May 5;12(1):7341
pubmed: 35513428
Health Econ Rev. 2015 Dec;5(1):51
pubmed: 26054487
Health Econ. 2010 Jan;19(1):43-55
pubmed: 19206080
J Am Geriatr Soc. 2013 Sep;61(9):1537-51
pubmed: 24028357